Skip to content

DTIL - PRECISION BIOSCIENCES INC - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchD

Precision BioSciences Inc

DTIL · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

D

DTILPrecision BioSciences Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $9.62
52-wk low: $3.53
Prev close: $6.44
Mkt cap: $234.6M
Fwd P/E: 11.8x
Beta: 1.23

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$20.3M

MW
Marshall Wace
Q1 2026 13F
$2.3M
position
TS
Two Sigma
Q2 2026 13F

Earnings

Reported Aug 6, 2026

Earnings came in 4.1% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -117.0%
Forward P/E: 11.78
Market cap: $235M

Valuation

P/S5.21
P/B5.02

Quality

Operating margin-80.8%

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: DTIL
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $234.61M
Beta: 1.23

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

5.2x

P/B

5.0x

Profit margin

-117.0%

Op margin

-80.8%

ROE

-135.1%

$1.9M

position

SQ

Squarepoint

Q2 2026 13F

$1.1M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for DTIL

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.71+4.1%

-$0.74 expected

Next report

What the street expects next

ROE

-135.1%

ROA-19.4%

Growth

Beta1.23